Companies / Akoya Biosciences, Inc.
Akoya Biosciences, Inc.
AKYACIK 1711933
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 12, 2023 | Raffin Thomas A. Director | Buy Open-market buy | Common Stock | $9.02M | +1.8M +12.76% | 15,937,535 | high |
| Jun 12, 2023 | Winkler Matthew Director | Buy Open-market buy | Common Stock | $1.02M | +203K +26.04% | 984,513 | high |
| Jun 12, 2023 | Raffin Thomas A. Director | Buy Open-market buy | Common Stock | $983.1K | +197K +12.76% | 1,737,712 | high |
| Dec 13, 2022 | Schnettler Thomas P Director | Sell Open-market sale | Common Stock | $925.8K | -71K -2.53% | 2,742,721 | medium |
| Jun 12, 2023 | Shepler Robert G Director | Buy Open-market buy | Common Stock | $600.0K | +120K +48.08% | 369,592 | high |
| Nov 22, 2021 | Ramachandran Niro Ph.D Executive | Buy Open-market buy | Common Stock | $328.3K | +25K +34246.58% | 25,073 | medium |
| Dec 9, 2021 | Nolan Garry Ph.D. Director | Sell Open-market sale | Common Stock | $316.8K | -25K -3.68% | 655,084 | medium |
| Sep 9, 2022 | Nolan Garry Ph.D. Director | Sell Open-market sale | Common Stock | $295.3K | -22K -3.39% | 632,893 | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| AKYA | common | 00974H104 |